Re:The Insanity Virus (2010)
by architek1 on Saturday December 13, 2014 @01:47PM
(#8745925)
It appears GeNuero has found 47 million dollars from investment partner, Servier, and "GNbAC1 has successfully completed Phase IIa, demonstrating an optimal safety profile and encouraging signs of efficacy on a first small cohort of patients." http://www.geneuro.com/en/news.php#news
[ Parent
| on HN ]
There are no comments on this comment yet.